Galapagos NV — Investor Relations & Filings
Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Transparantieverklaring | 2019-08-30 | Dutch | |
| Transparantieverklaring | 2019-08-30 | Dutch | |
| Transparantieverklaring | 2019-08-30 | Dutch | |
| Transparantieverklaring | 2019-08-30 | Dutch | |
| Transparency notification | 2019-08-30 | English | |
| Transparency notification | 2019-08-30 | English |
Browse filings by year
22 years- 2026 106 filings
- 2025 162 filings
- 2024 118 filings
- 2023 121 filings
- 2022 167 filings
- 2021 183 filings
- 2020 156 filings
- 2019 324 filings
- 2018 205 filings
- 2017 196 filings
- 2016 217 filings
- 2015 187 filings
- 2014 183 filings
- 2013 142 filings
- 2012 105 filings
- 2011 124 filings
- 2010 42 filings
- 2009 39 filings
- 2008 31 filings
- 2007 27 filings
- 2006 15 filings
- 2005 12 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
15 filings
| |||||
| 10818560 | Transparantieverklaring | 2019-08-30 | Dutch | ||
| 10818559 | Transparantieverklaring | 2019-08-30 | Dutch | ||
| 10818557 | Transparantieverklaring | 2019-08-30 | Dutch | ||
| 10818556 | Transparantieverklaring | 2019-08-30 | Dutch | ||
| 10818555 | Transparency notification | 2019-08-30 | English | ||
| 10818554 | Transparency notification | 2019-08-30 | English | ||
| 10818553 | Transparency notification | 2019-08-30 | English | ||
| 10818552 | Transparency notification | 2019-08-30 | English | ||
| 10818551 | Transparantieverklaring | 2019-08-30 | Dutch | ||
| 1090840 | Transparency notification | 2019-08-30 | English | ||
| 3157640 | VANHERK 30 AUG 2019.pdf | 2019-08-30 | English | ||
| 3157637 | VANHERK 30 AUG 2019_NL.pdf | 2019-08-30 | Dutch | ||
| 2490904 | Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen | 2019-08-29 | English | ||
| 2490902 | Transparantieverklaring – Gilead bezit 22% van de Galapagos aandelen | 2019-08-29 | Dutch | ||
| 29672961 | 6-K Filing | 2019-08-29 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Galapagos NV, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Galapagos NV via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/3954/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=3954 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=3954 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=3954 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 3954}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Galapagos NV (id: 3954)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.